NCT05161494View on ClinicalTrials.gov

Gait in Rare Diseases

Active, not recruitingOBSERVATIONAL
Enrollment

70

Participants

Timeline

Start Date

January 25, 2022

Primary Completion Date

July 1, 2025

Study Completion Date

January 30, 2026

Conditions
Tuberous SclerosisSTXBP1 Encephalopathy With Epilepsy
Trial Locations (1)

2160

University of Antwerp, Antwerp

All Listed Sponsors
collaborator

University Hospital, Antwerp

OTHER

lead

Universiteit Antwerpen

OTHER